Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Chiral Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the advanced asymmetric hydrogenation process for levo-nicotine. Achieve 99.7% optical purity with scalable, cost-effective pharmaceutical intermediate manufacturing.
Patent CN111233829A details a mild asymmetric reduction method for high-purity nicotine, offering significant cost reduction in fine chemical manufacturing and scalable supply chain solutions.
Patent CN119306599A details a high-yield asymmetric hydrogenation route for Vaborbactam intermediates, offering significant cost reduction and supply chain reliability for global pharma manufacturers.
Patent CN103288876B details a novel chiral phosphamide synthesis. Discover cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN101142164B details a cost-effective route to Synthon A using planar chiral diphosphine catalysts, offering high ee and scalability for API manufacturing.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN104854071B details asymmetric hydrogenation for high-purity tocopherol precursors. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.
Advanced asymmetric oxidation process for high-purity Esomeprazole Sodium. Reduces impurities and enhances supply chain stability for global pharmaceutical manufacturers.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Novel Ru-BINAP catalyzed route for (R)-5'-methoxylaudanosine. High purity >99.98% ee, non-genotoxic process, scalable for Mivacurium Chloride production.
Patent CN113666915B reveals a novel 5-step route for posaconazole intermediates using chiral iron catalysis, offering high purity and scalable manufacturing for global supply chains.
Novel Rh-catalyzed asymmetric hydrogenation route for Pramipexole. Higher yield, lower cost, industrial scale ready. Ideal for pharma intermediates.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN101429192A details a novel chiral titanium catalysis method for high-purity proton pump inhibitor intermediates, offering significant supply chain and cost advantages.
Patent CN102977076A reveals a high-purity R-lansoprazole synthesis using chiral titanium catalysis. Discover cost-effective manufacturing insights for pharmaceutical supply chains.
Novel asymmetric catalysis method improves yield and purity for Carfilzomib intermediate manufacturing ensuring supply chain stability and cost efficiency.